UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014383
Receipt number R000016742
Scientific Title A prospective randomized control study of combination therapy with low-dose methimazole and a cholesterol absorption inhibitor as for the initial treatment of childhood-onset Graves disease
Date of disclosure of the study information 2014/06/27
Last modified on 2021/01/07 08:16:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective randomized control study of combination therapy with low-dose methimazole and a cholesterol absorption inhibitor as for the initial treatment of childhood-onset Graves disease

Acronym

A prospective randomized control study of combination therapy with low-dose methimazole and a cholesterol absorption inhibitor as for the initial treatment of childhood-onset Graves disease

Scientific Title

A prospective randomized control study of combination therapy with low-dose methimazole and a cholesterol absorption inhibitor as for the initial treatment of childhood-onset Graves disease

Scientific Title:Acronym

A prospective randomized control study of combination therapy with low-dose methimazole and a cholesterol absorption inhibitor as for the initial treatment of childhood-onset Graves disease

Region

Japan


Condition

Condition

Graves disease

Classification by specialty

Endocrinology and Metabolism Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The objective of this study was to examine the efficacy and safety of combination therapy with methimazole and a cholesterol absorption inhibitor as for the initial treatment of childhood-onset Graves disease

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The normalization rate of levels of free T4 and free T3 at the 4 weeks treatment.

Key secondary outcomes

Time to relief of hyperthyroid symptoms
The normalization rate of levels of free T4 and free T3 at the 8, 12, and 24 weeks treatment.
Change of levels of TRAb, Total cholesterol, CPK and 25 hydroxy vitamin D


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

methimazole

Interventions/Control_2

methimazole and a cholesterol absorption inhibitor (colestimide)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

10 years-old <=

Age-upper limit

16 years-old >

Gender

Male and Female

Key inclusion criteria

1) Patients with newly diagnosed Graves' disease
2) Serum FT4 value more than 5.0 ng/dl
3) Written informed consent from the patients' parents or legal guardians.

Key exclusion criteria

1) Patients with thyrotoxic crisis
2) Patients who receive pharmacotherapy for diabetes, hepatic and renal disease
3) Medical history of Graves disease. Patients who have already used cholesterol absorption inhibitor.
4) Use of coumarin anticoagulants, digitalis, and bile acids preparations
5) Judged inappropriate for this study by the physicians.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Keisuke Nagasaki

Organization

Niigata University Medical & Dental Hospital

Division name

Pediatrics

Zip code


Address

1-757 Asahimachi-Dori, Chu-Ou-Ku, Niigata city, Niigata

TEL

025-227-2222

Email

nagasaki@med.niigata-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Keisuke Nagasaki

Organization

ABC Tx Group

Division name

Department of Pediatrics, Niigata University

Zip code


Address

1-757 Asahimachi-Dori, Chu-Ou-Ku, Niigata city, Niigata

TEL

025-227-2222

Homepage URL


Email

nagasaki@med.niigata-u.ac.jp


Sponsor or person

Institute

ABC Tx group

Institute

Department

Personal name



Funding Source

Organization

MEXT(Japan)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

新潟大学医歯学総合病院、都立小児総合医療センター、宮崎大学医学部附属病院、大阪大学医学部附属病院、あいち小児保健医療総合センター、久留米大学病院、群馬大学医学部附属病院、長崎大学病院、金沢医科大学病院、順天堂大学医学部附属順天堂医院、聖マリアンナ医科大学病院、東京医科歯科大学医学部附属病院、東邦大学医療センター大森病院、山形大学医学部附属病院、住友別子病院、川崎市立川崎病院、名古屋市立大学病院、京都府立医科大学附属病院、信州大学医学部附属病院、磐田市立総合病院、北里大学病院、神奈川県立こども医療センター、北海道大学病院、慶応義塾大学病院、国立病院機構 四国こどもとおとなの医療センター、岩手医科大学附属病院、東北大学病院、愛媛大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2014 Year 06 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2014 Year 05 Month 12 Day

Date of IRB

2013 Year 11 Month 13 Day

Anticipated trial start date

2014 Year 06 Month 27 Day

Last follow-up date

2020 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 06 Month 26 Day

Last modified on

2021 Year 01 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016742


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name